6533b873fe1ef96bd12d4bb2
RESEARCH PRODUCT
Combination of bexarotene and rosuvastatin at sub-optimal doses impairs angiotensin ii-induced arterial mononuclear cell adhesion
Herminia González-navarroV. LopezMaría José SanzP. EscuderoLaura Piquerassubject
BexaroteneChemistrymedicineRosuvastatinAdhesionPharmacologyCardiology and Cardiovascular MedicinePeripheral blood mononuclear cellAngiotensin IImedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2014-08-01 | Atherosclerosis |